| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.01B | $987.3M | $815.9M |
| YoY Revenue Growth % | +1.8% | +21.0% | — |
| Gross Profit | $499.8M | $515.3M | — |
| Gross Margin % | 49.7% | 52.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $132.9M | $187.1M | $116.1M |
| Operating Margin % | 13.2% | 19.0% | 14.2% |
| Net Income (GAAP) | $136.8K | $201.7K | $121.2K |
| EBITDA (Normalized) | $155.7M | $212.6M | $145.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $328.3M | $245.7M | $172.0M |
| Capital Expenditures (CapEx) | $28.5M | $31.9M | $36.7M |
| Free Cash Flow (FCF) | $299.8M | $213.8M | $135.3M |
| FCF Margin % | 29.8% | 21.7% | 16.6% |
| Return on Invested Capital (ROIC %) | 5.6% | 8.2% | 2.5% |
| Cash & Short-Term Equivalents | $346.1M | $212.9M | — |
| Total Debt (Short + Long Term) | $120.2M | $86.0M | $1.40B |
| Total Stockholders' Equity | $2.10B | $1.93B | $2.87B |